From Nasdaq.: 2025-02-06 21:35:46

RenovoRx Inc. (RNXT) has priced a public offering of 11.52 million shares of common stock at $1.05 per share, expecting to raise $12.1 million. The offering is set to close on February 10, 2025. The company plans to use the proceeds for working capital, advancing its Phase III TIGeR-PaC study, and commercial sales and marketing for RenovoCath.



Read more at Nasdaq.: RenovoRx Announces Pricing Of Public Offering Of About 11.52 Million Shares At $1.05/shr